Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2005 2
2006 1
2007 4
2009 3
2010 2
2011 2
2012 3
2014 3
2015 4
2016 3
2017 3
2018 2
2019 4
2020 5
2021 6
2022 4
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Compartmentalization of galactan biosynthesis in mycobacteria.
Savková K, Danchenko M, Fabianová V, Bellová J, Bencúrová M, Huszár S, Korduláková J, Siváková B, Baráth P, Mikušová K. Savková K, et al. Among authors: kordulakova j. J Biol Chem. 2024 Mar;300(3):105768. doi: 10.1016/j.jbc.2024.105768. Epub 2024 Feb 16. J Biol Chem. 2024. PMID: 38367664 Free PMC article.
Both Nitro Groups Are Essential for High Antitubercular Activity of 3,5-Dinitrobenzylsulfanyl Tetrazoles and 1,3,4-Oxadiazoles through the Deazaflavin-Dependent Nitroreductase Activation Pathway.
Karabanovich G, Fabiánová V, Vocat A, Dušek J, Valášková L, Stolaříková J, Kitson RRA, Pávek P, Vávrová K, Djaout K, Mikušová K, Baulard AR, Cole ST, Korduláková J, Roh J. Karabanovich G, et al. Among authors: kordulakova j. J Med Chem. 2024 Jan 11;67(1):81-109. doi: 10.1021/acs.jmedchem.3c00925. Epub 2023 Dec 29. J Med Chem. 2024. PMID: 38157261 Free PMC article.
Correction to "Hybridization Approach Toward Novel Antituberculars: Design, Synthesis, and Biological Evaluation of Compounds Combining Pyrazinamide and 4-Aminosalicylic Acid".
Bouz G, Šlechta P, Jand'ourek O, Konečná K, Paterová P, Bárta P, Novák M, Kučera R, Dal NK, Fenaroli F, Zemanová J, Forbak M, Korduláková J, Pavliš O, Kubíčková P, Doležal M, Zitko J. Bouz G, et al. Among authors: kordulakova j. ACS Infect Dis. 2023 Aug 11;9(8):1674. doi: 10.1021/acsinfecdis.3c00335. Epub 2023 Jul 24. ACS Infect Dis. 2023. PMID: 37486740 No abstract available.
Discovery of new diaryl ether inhibitors against Mycobacterium tuberculosis targeting the minor portal of InhA.
Chebaiki M, Delfourne E, Tamhaev R, Danoun S, Rodriguez F, Hoffmann P, Grosjean E, Goncalves F, Azéma-Despeyroux J, Pál A, Korduláková J, Preuilh N, Britton S, Constant P, Marrakchi H, Maveyraud L, Mourey L, Lherbet C. Chebaiki M, et al. Among authors: kordulakova j. Eur J Med Chem. 2023 Nov 5;259:115646. doi: 10.1016/j.ejmech.2023.115646. Epub 2023 Jul 16. Eur J Med Chem. 2023. PMID: 37482022
Antimycobacterial pyridine carboxamides: From design to in vivo activity.
Nawrot DE, Bouz G, Janďourek O, Konečná K, Paterová P, Bárta P, Novák M, Kučera R, Zemanová J, Forbak M, Korduláková J, Pavliš O, Kubíčková P, Doležal M, Zitko J. Nawrot DE, et al. Among authors: kordulakova j. Eur J Med Chem. 2023 Oct 5;258:115617. doi: 10.1016/j.ejmech.2023.115617. Epub 2023 Jun 30. Eur J Med Chem. 2023. PMID: 37423128 Free article.
Exploring the Antitubercular Activity of Anthranilic Acid Derivatives: From MabA (FabG1) Inhibition to Intrabacterial Acidification.
Faïon L, Djaout K, Pintiala C, Piveteau C, Leroux F, Biela A, Slupek S, Antoine R, Záhorszká M, Cantrelle FX, Hanoulle X, Korduláková J, Deprez B, Willand N, Baulard AR, Flipo M. Faïon L, et al. Among authors: kordulakova j. Pharmaceuticals (Basel). 2023 Feb 22;16(3):335. doi: 10.3390/ph16030335. Pharmaceuticals (Basel). 2023. PMID: 36986435 Free PMC article.
Hybridization Approach Toward Novel Antituberculars: Design, Synthesis, and Biological Evaluation of Compounds Combining Pyrazinamide and 4-Aminosalicylic Acid.
Bouz G, Šlechta P, Jand'ourek O, Konečná K, Paterová P, Bárta P, Novák M, Kučera R, Dal NK, Fenaroli F, Zemanová J, Forbak M, Korduláková J, Pavliš O, Kubíčková P, Doležal M, Zitko J. Bouz G, et al. Among authors: kordulakova j. ACS Infect Dis. 2023 Jan 13;9(1):79-96. doi: 10.1021/acsinfecdis.2c00433. Epub 2022 Dec 28. ACS Infect Dis. 2023. PMID: 36577009
A New Benzothiazolthiazolidine Derivative, 11726172, Is Active In Vitro, In Vivo, and against Nonreplicating Cells of Mycobacterium tuberculosis.
Salina EG, Postiglione U, Chiarelli LR, Recchia D, Záhorszká M, Lepioshkin A, Monakhova N, Pál A, Porta A, Zanoni G, Korduláková J, Kazakova E, Sassera D, Pasca MR, Makarov V, Degiacomi G. Salina EG, et al. Among authors: kordulakova j. mSphere. 2022 Dec 21;7(6):e0036922. doi: 10.1128/msphere.00369-22. Epub 2022 Nov 15. mSphere. 2022. PMID: 36377880 Free PMC article.
Bioinformatic Mining and Structure-Activity Profiling of Baeyer-Villiger Monooxygenases from Mycobacterium tuberculosis.
Tomas N, Leonelli D, Campoy M, Marthey S, Le NH, Rengel D, Martin V, Pál A, Korduláková J, Eynard N, Guillet V, Mourey L, Daffé M, Lemassu A, André G, Marrakchi H. Tomas N, et al. Among authors: kordulakova j. mSphere. 2022 Apr 27;7(2):e0048221. doi: 10.1128/msphere.00482-21. Epub 2022 Mar 17. mSphere. 2022. PMID: 35296143 Free PMC article.
57 results